Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Pharmacology|February 23, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trialsBeatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.Chimia|December 9, 2023
Current HDAC Inhibitors in Clinical TrialsElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.Frontiers in Chemistry|July 7, 2020
The Innovative Potential of Statins in Cancer: New Targets for New TherapiesElisabetta Di Bello, Clemens Zwergel, Antonello Mai, et al.Molecules (Basel, Switzerland)|July 12, 2020
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer CellsRossella Fioravanti, Stefano Tomassi, Elisabetta Di Bello, et al.Chemmedchem|November 21, 2020
Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer ActivityClemens Zwergel, Elisabetta Di Bello, Rossella Fioravanti, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.ACS Medicinal Chemistry Letters|May 22, 2020
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer CellsAnnalisa Romanelli, Giulia Stazi, Rossella Fioravanti, et al.Frontiers in Endocrinology|June 17, 2022
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage ResponseCamilla Cristalli, Maria Cristina Manara, Sergio Valente, et al.ACS Infectious Diseases|June 22, 2022
Effects of Structurally Different HDAC Inhibitors against Trypanosoma cruzi, Leishmania, and Schistosoma mansoniElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.Chemmedchem|October 17, 2022
Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult StagesBeatrice Noce, Elisabetta Di Bello, Clemens Zwergel, et al.Pageof 2